---
draft: true # ← Will not appear in published site
---

## Step 6: Screening and Study Selection

Study selection typically occurs in two stages: title/abstract screening
followed by full-text review.

### Comprehensive Screening Workflow

```
┌──────────────────────────────────────────────────────────────┐
│           COMPLETE SCREENING WORKFLOW                         │
└──────────────────────────────────────────────────────────────┘

PREPARATION PHASE (Week 1)
│
├─ Day 1-2: Screening Tool Setup
│  ├─ Choose platform (Covidence, Rayyan, DistillerSR)
│  ├─ Import all citations
│  ├─ Configure screening questions
│  ├─ Set up eligibility criteria checklist
│  └─ Test workflow with 5 sample citations
│
├─ Day 3: Team Training
│  ├─ Review eligibility criteria
│  ├─ Practice on 10 test citations
│  ├─ Discuss challenging scenarios
│  ├─ Establish decision rules
│  └─ Set conflict resolution process
│
└─ Day 4-5: Pilot Screening
   ├─ Both reviewers screen same 50 citations
   ├─ Compare results
   ├─ Calculate Cohen's kappa
   ├─ Discuss disagreements
   ├─ Refine criteria if needed
   └─ Document changes

TITLE/ABSTRACT SCREENING (Week 2-4)
│
├─ Independent Screening
│  ├─ Reviewer 1 & 2 work independently
│  ├─ No communication during screening
│  ├─ Flag uncertain citations for discussion
│  └─ Target: 100-200 citations per reviewer per day
│
├─ Screening Questions (for each citation)
│  ├─ Q1: Correct population? (Yes/No/Unclear)
│  ├─ Q2: Correct intervention/exposure? (Yes/No/Unclear)
│  ├─ Q3: Correct study design? (Yes/No/Unclear)
│  ├─ Q4: Relevant outcomes reported? (Yes/No/Unclear)
│  └─ Decision: Include / Exclude / Maybe
│
├─ Decision Rules
│  ├─ All "Yes" → INCLUDE
│  ├─ Any "No" (with certainty) → EXCLUDE
│  ├─ Any "Unclear" → INCLUDE (review at full-text)
│  └─ When in doubt → INCLUDE
│
└─ Weekly Progress Review
   ├─ Check screening pace
   ├─ Discuss challenging citations
   ├─ Monitor agreement rates
   └─ Adjust timeline if needed

CONFLICT RESOLUTION (Ongoing)
│
├─ Automatic Conflicts
│  ├─ R1: Include vs R2: Exclude
│  └─ Flag for discussion
│
├─ Resolution Process
│  ├─ Both reviewers discuss rationale
│  ├─ Re-review eligibility criteria
│  ├─ Reach consensus if possible
│  ├─ If no consensus → Third reviewer
│  └─ Document final decision + rationale
│
└─ Agreement Tracking
   ├─ Calculate kappa at 25%, 50%, 75%, 100%
   ├─ Target: Kappa >0.60
   └─ If kappa drops, retrain and recalibrate

FULL-TEXT RETRIEVAL (Week 5)
│
├─ Identify All Potentially Relevant Citations
│  └─ All "Include" and "Maybe" from title/abstract
│
├─ Retrieval Methods (in order)
│  ├─ 1. Direct download (open access)
│  ├─ 2. Institution library access
│  ├─ 3. Interlibrary loan request
│  ├─ 4. Author contact via email
│  ├─ 5. ResearchGate request
│  └─ 6. Note as "unable to retrieve"
│
├─ Organization
│  ├─ Create folder: "Full_Texts_For_Review"
│  ├─ Name files: "FirstAuthor_Year_ShortTitle.pdf"
│  ├─ Link to citation in database
│  └─ Track retrieval status
│
└─ Retrieval Tracking
   | Status | Count | % |
   |--------|-------|---|
   | Retrieved | 267 | 97% |
   | In progress | 5 | 2% |
   | Unobtainable | 3 | 1% |
   | TOTAL | 275 | 100% |

FULL-TEXT SCREENING (Week 6-8)
│
├─ Independent Full-Text Review
│  ├─ Reviewer 1 & 2 independently
│  ├─ Read full text carefully
│  ├─ Apply ALL eligibility criteria
│  ├─ Document specific exclusion reasons
│  └─ Target: 10-15 papers per reviewer per day
│
├─ Detailed Screening Form
│  For each paper:
│  ├─ Study Design
│  │  ├─ Type: __________
│  │  └─ Meets criteria? Y/N
│  │
│  ├─ Population
│  │  ├─ N = ____
│  │  ├─ Age range: ____
│  │  ├─ Diagnosis method: ____
│  │  └─ Meets criteria? Y/N
│  │
│  ├─ Intervention/Exposure
│  │  ├─ Description: ____
│  │  ├─ Duration: ____
│  │  └─ Meets criteria? Y/N
│  │
│  ├─ Comparison
│  │  ├─ Description: ____
│  │  └─ Meets criteria? Y/N
│  │
│  ├─ Outcomes
│  │  ├─ Primary: ____
│  │  ├─ Secondary: ____
│  │  └─ Meets criteria? Y/N
│  │
│  └─ Other Criteria
│     ├─ Language: ____
│     ├─ Date: ____
│     ├─ Publication type: ____
│     └─ All met? Y/N
│
├─ Exclusion Reasons (Primary only)
│  Use predefined categories:
│  ├─ 1. Wrong population
│  ├─ 2. Wrong intervention/exposure
│  ├─ 3. Wrong comparison
│  ├─ 4. Wrong outcomes
│  ├─ 5. Wrong study design
│  ├─ 6. Wrong publication type
│  ├─ 7. Language
│  ├─ 8. Duplicate/multiple publication
│  └─ 9. Other (specify)
│
└─ Conflict Resolution
   ├─ Discuss all conflicts
   ├─ Third reviewer if needed
   ├─ Document decisions
   └─ Create exclusion table

FINAL SELECTION (Week 9)
│
├─ Compile Final Included Studies List
│  ├─ All studies passing full-text review
│  ├─ Verify no duplicates
│  ├─ N = ____ studies
│  └─ Create master spreadsheet
│
├─ Create PRISMA Flow Diagram
│  ├─ Numbers at each stage
│  ├─ Exclusion reasons with counts
│  ├─ Visual representation
│  └─ Review with team
│
└─ Documentation
   ├─ List of excluded studies with reasons
   ├─ Inter-rater agreement statistics
   ├─ Screening timeline actual vs planned
   └─ Notes on challenging decisions

ESTIMATED TIME: 9 weeks total
├─ Preparation: 1 week
├─ Title/Abstract: 3 weeks (for ~4,000 citations)
├─ Retrieval: 1 week
└─ Full-Text: 3-4 weeks (for ~270 papers)
```

### PRISMA 2020 Flow Diagram

```
┌─────────────────────────────────────────────────────────────┐
│                     IDENTIFICATION                          │
├─────────────────────────────────────────────────────────────┤
│                                                             │
│  Records identified from:              Records identified   │
│  Databases (n = 4,739)                 from other sources:  │
│  • PubMed (n = 1,247)                  • Citation (n = 78)  │
│  • Embase (n = 1,834)                  • Gray lit (n = 34)  │
│  • Cochrane (n = 156)                  • Hand (n = 12)      │
│  • CINAHL (n = 423)                                         │
│  • Web of Science (n = 967)            (n = 124)            │
│  • Registers (n = 112)                                      │
│                                                             │
└────────────────────┬────────────────────────────────────────┘
                     │
                     ▼
┌─────────────────────────────────────────────────────────────┐
│  Records removed before screening:                          │
│  • Duplicate records (n = 909)                              │
│  • Records marked ineligible by automation tools (n = 112)  │
└────────────────────┬────────────────────────────────────────┘
                     │
                     ▼
┌─────────────────────────────────────────────────────────────┐
│                      SCREENING                              │
├─────────────────────────────────────────────────────────────┤
│                                                             │
│  Records screened                    Records excluded       │
│  (n = 3,842)                        (n = 3,567)             │
│                                                             │
└────────────────────┬────────────────────────────────────────┘
                     │
                     ▼
┌─────────────────────────────────────────────────────────────┐
│  Reports sought for retrieval        Reports not retrieved  │
│  (n = 275)                          (n = 8)                 │
│                                                             │
└────────────────────┬────────────────────────────────────────┘
                     │
                     ▼
┌─────────────────────────────────────────────────────────────┐
│  Reports assessed for eligibility  Reports excluded:        │
│  (n = 267)                         (n = 224)                │
│                                    • Wrong population (87)  │
│                                    • Wrong intervention (56)│
│                                    • Wrong outcome (42)     │
│                                    • Wrong study design (29)│
│                                    • Wrong publication (10) │
└────────────────────┬────────────────────────────────────────┘
                     │
                     ▼
┌─────────────────────────────────────────────────────────────┐
│                      INCLUDED                               │
├─────────────────────────────────────────────────────────────┤
│                                                             │
│  Studies included in review                                 │
│  (n = 43)                                                   │
│                                                             │
│  Reports of included studies                                │
│  (n = 43)                                                   │
│                                                             │
└─────────────────────────────────────────────────────────────┘
```

### Screening Process Workflow

| Stage | Process | Reviewers | Tool | Output |
|-------|---------|-----------|------|--------|
| **Title/Abstract** | Quick screening against broad eligibility | 2 independent | Covidence/Rayyan | Include/Exclude/Uncertain |
| **Conflict Resolution** | Discuss disagreements | 2 + 1 arbiter if needed | Discussion meeting | Consensus decision |
| **Full-Text** | Detailed assessment against all criteria | 2 independent | Covidence/Manual | Include/Exclude with reason |
| **Final Selection** | Resolve conflicts, finalize list | 2 + 1 arbiter | Discussion meeting | Final included studies |

### Inter-Rater Reliability

| Kappa Value | Interpretation | Action Needed |
|-------------|----------------|---------------|
| < 0.20 | Poor agreement | Review criteria, retrain reviewers, discuss discrepancies |
| 0.21 - 0.40 | Fair agreement | Clarify criteria, discuss challenging cases |
| 0.41 - 0.60 | Moderate agreement | Minor refinements to process |
| 0.61 - 0.80 | Good agreement | Continue with current process |
| 0.81 - 1.00 | Excellent agreement | Process working well |

### Search Strategy Development Process

```
┌─────────────────────────────────────────────────────────────┐
│              SEARCH STRATEGY DEVELOPMENT                     │
└─────────────────────────────────────────────────────────────┘
    │
    ├─▶ STEP 1: Identify Key Concepts from PICO
    │   • Break down each component
    │   • List main concepts
    │
    ├─▶ STEP 2: Generate Synonyms and Related Terms
    │   • Use thesauri and dictionaries
    │   • Consider spelling variations
    │   • Include acronyms and abbreviations
    │
    ├─▶ STEP 3: Identify Database Subject Headings
    │   • MeSH terms (PubMed)
    │   • Emtree terms (Embase)
    │   • Check each database's controlled vocabulary
    │
    ├─▶ STEP 4: Build Search Strings
    │   • Combine synonyms with OR
    │   • Combine concepts with AND
    │   • Use truncation (*) and wildcards (?)
    │   • Apply proximity operators (NEAR, ADJ)
    │
    ├─▶ STEP 5: Add Filters
    │   • Date range
    │   • Language
    │   • Publication type
    │   • Study design (if possible)
    │
    ├─▶ STEP 6: Pilot Test
    │   • Run in one database
    │   • Check sample of results
    │   • Verify known studies are captured
    │
    ├─▶ STEP 7: Refine
    │   • Adjust sensitivity/specificity
    │   • Add missing terms
    │   • Remove ineffective terms
    │
    └─▶ STEP 8: Adapt for Each Database
        • Modify syntax as needed
        • Translate subject headings
        • Document all variations
```

### Sample Search Strategy

**Example Topic**: Mediterranean diet and glycemic control in type 2 diabetes

| Concept | Search Terms | Combined With |
|---------|--------------|---------------|
| **Population** | ("diabetes mellitus, type 2"[MeSH] OR "type 2 diabetes" OR "T2DM" OR "adult onset diabetes" OR "non-insulin dependent diabetes" OR "NIDDM") | AND |
| **Intervention** | ("diet, mediterranean"[MeSH] OR "mediterranean diet*" OR "Mediterranean-style diet*" OR "MedDiet" OR "med diet") | AND |
| **Outcome** | ("glycated hemoglobin"[MeSH] OR "HbA1c" OR "hemoglobin A1c" OR "glycemic control" OR "blood glucose" OR "fasting glucose" OR "glucose control") | — |
| **Filters** | English language, January 2010-present, Humans | — |

**Combined Search String**:
```
("diabetes mellitus, type 2"[MeSH] OR "type 2 diabetes" OR "T2DM" OR 
"adult onset diabetes" OR "non-insulin dependent diabetes" OR "NIDDM")
AND
("diet, mediterranean"[MeSH] OR "mediterranean diet*" OR 
"Mediterranean-style diet*" OR "MedDiet" OR "med diet")
AND
("glycated hemoglobin"[MeSH] OR "HbA1c" OR "hemoglobin A1c" OR 
"glycemic control" OR "blood glucose" OR "fasting glucose" OR 
"glucose control")
Filters: English, 2010-present, Humans
```

### Search Documentation Template

| Database | Platform | Date | Search # | Search Terms | Limiters | Results |
|----------|----------|------|----------|--------------|----------|---------|
| PubMed | NLM | 2025-03-15 | #1 | "diabetes mellitus, type 2"[MeSH] | None | 156,823 |
| PubMed | NLM | 2025-03-15 | #2 | "type 2 diabetes" OR T2DM OR NIDDM | None | 203,456 |
| PubMed | NLM | 2025-03-15 | #3 | #1 OR #2 | None | 245,789 |
| PubMed | NLM | 2025-03-15 | #4 | "diet, mediterranean"[MeSH] OR "mediterranean diet*" | None | 3,456 |
| PubMed | NLM | 2025-03-15 | #5 | #3 AND #4 | None | 234 |
| PubMed | NLM | 2025-03-15 | #6 | #5 AND ("HbA1c" OR "glycemic control"...) | English, 2010-present | 87 |
